BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 29358437)

  • 1. Developing a dementia-specific preference--based quality of life measure (AD-5D) in Australia: a valuation study protocol.
    Comans TA; Nguyen KH; Mulhern B; Corlis M; Li L; Welch A; Kurrle SE; Rowen D; Moyle W; Kularatna S; Ratcliffe J
    BMJ Open; 2018 Jan; 8(1):e018996. PubMed ID: 29358437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing a dementia-specific health state classification system for a new preference-based instrument AD-5D.
    Nguyen KH; Mulhern B; Kularatna S; Byrnes J; Moyle W; Comans T
    Health Qual Life Outcomes; 2017 Jan; 15(1):21. PubMed ID: 28122626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valuing the AD-5D Dementia Utility Instrument: An Estimation of a General Population Tariff.
    Comans TA; Nguyen KH; Ratcliffe J; Rowen D; Mulhern B
    Pharmacoeconomics; 2020 Aug; 38(8):871-881. PubMed ID: 32314315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developing a new quality of life instrument with older people for economic evaluation in aged care: study protocol.
    Ratcliffe J; Cameron I; Lancsar E; Walker R; Milte R; Hutchinson CL; Swaffer K; Parker S
    BMJ Open; 2019 May; 9(5):e028647. PubMed ID: 31129602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation study of the prototype of a disease-specific index measure for health-related quality of life in dementia.
    Schölzel-Dorenbos CJ; Arons AM; Wammes JJ; Rikkert MG; Krabbe PF
    Health Qual Life Outcomes; 2012 Sep; 10():118. PubMed ID: 23009579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valuation study for a preference-based quality of life measure for dental caries (Dental Caries Utility Index - DCUI) among Australian adolescents - study protocol.
    Hettiarachchi R; Kularatna S; Byrnes J; Mulhern B; Chen G; Scuffham PA
    BMJ Open; 2020 Oct; 10(10):e038626. PubMed ID: 33087374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing a cerebral palsy-specific preference-based measure for a six-dimensional classification system (CP-6D): protocol for a valuation study.
    Bahrampour M; Norman R; Byrnes J; Downes M; Scuffham PA
    BMJ Open; 2019 Sep; 9(9):e029325. PubMed ID: 31515422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Producing a preference-based quality of life measure for people with Duchenne muscular dystrophy: a mixed-methods study protocol.
    Powell PA; Carlton J; Rowen D; Brazier JE
    BMJ Open; 2019 Mar; 9(3):e023685. PubMed ID: 30852532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health utility scores in Alzheimer's disease: differences based on calculation with American and Canadian preference weights.
    Oremus M; Tarride JE; Clayton N; ; Raina P
    Value Health; 2014; 17(1):77-83. PubMed ID: 24438720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valuing the Child Health Utility 9D: Using profile case best worst scaling methods to develop a new adolescent specific scoring algorithm.
    Ratcliffe J; Huynh E; Chen G; Stevens K; Swait J; Brazier J; Sawyer M; Roberts R; Flynn T
    Soc Sci Med; 2016 May; 157():48-59. PubMed ID: 27060541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-related quality of life in people with predementia Alzheimer's disease, mild cognitive impairment or dementia measured with preference-based instruments: a systematic literature review.
    Landeiro F; Mughal S; Walsh K; Nye E; Morton J; Williams H; Ghinai I; Castro Y; Leal J; Roberts N; Wace H; Handels R; Lecomte P; Gustavsson A; Roncancio-Diaz E; Belger M; Jhuti GS; Bouvy JC; Potashman MH; Tockhorn-Heidenreich A; Gray AM;
    Alzheimers Res Ther; 2020 Nov; 12(1):154. PubMed ID: 33208190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health state values for use in the economic evaluation of treatments for Alzheimer's disease.
    Shearer J; Green C; Ritchie CW; Zajicek JP
    Drugs Aging; 2012 Jan; 29(1):31-43. PubMed ID: 22191721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of DEMQOL-U and DEMQOL-PROXY-U: generation of preference-based indices from DEMQOL and DEMQOL-PROXY for use in economic evaluation.
    Mulhern B; Rowen D; Brazier J; Smith S; Romeo R; Tait R; Watchurst C; Chua KC; Loftus V; Young T; Lamping D; Knapp M; Howard R; Banerjee S
    Health Technol Assess; 2013 Feb; 17(5):v-xv, 1-140. PubMed ID: 23402232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of health utility scores calculated using United Kingdom and Canadian preference weights in persons with alzheimer's disease and their caregivers.
    Fang M; Oremus M; Tarride JE; Raina P;
    Health Qual Life Outcomes; 2016 Jul; 14(1):105. PubMed ID: 27431327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How Should Discrete Choice Experiments with Duration Choice Sets Be Presented for the Valuation of Health States?
    Mulhern B; Norman R; Shah K; Bansback N; Longworth L; Viney R
    Med Decis Making; 2018 Apr; 38(3):306-318. PubMed ID: 29084472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UK General Population Utility Values for the SIDECAR-D Instrument Measuring the Impact of Caring for People With Dementia.
    Webb EJD; Meads D; Al-Janabi H; Kind P; Torelli F; Horton M; Oyebode J; Wright P
    Value Health; 2020 Aug; 23(8):1079-1086. PubMed ID: 32828221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related quality of life measured using the EQ-5D-5L: South Australian population norms.
    McCaffrey N; Kaambwa B; Currow DC; Ratcliffe J
    Health Qual Life Outcomes; 2016 Sep; 14(1):133. PubMed ID: 27644755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of quality of life in Alzheimer's disease. Part 1: Issues in assessing disease impact.
    Walker MD; Salek SS; Bayer AJ
    Pharmacoeconomics; 1998 Nov; 14(5):499-530. PubMed ID: 10344915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health-Related Quality of Life in Patients with Alzheimer's Disease in Different German Health Care Settings.
    Heßmann P; Seeberg G; Reese JP; Dams J; Baum E; Müller MJ; Dodel R; Balzer-Geldsetzer M
    J Alzheimers Dis; 2016; 51(2):545-61. PubMed ID: 26890754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing adolescent-specific health state values for economic evaluation: an application of profile case best-worst scaling to the Child Health Utility 9D.
    Ratcliffe J; Flynn T; Terlich F; Stevens K; Brazier J; Sawyer M
    Pharmacoeconomics; 2012 Aug; 30(8):713-27. PubMed ID: 22788261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.